New Research: Key Drivers of Growth for Tiffany, CarMax,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
217
New Research: Key Drivers of Growth for Tiffany, CarMax, Cars, RPC, Cleveland-Cliffs, and Catabasis Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Tiffany & Co. (NYSE: TIF ), CarMax, Inc. (NYSE: KMX ), Cars.com Inc. (NYSE: CARS ), RPC, Inc. (NYSE: RES ), Cleveland-Cliffs Inc. (NYSE: CLF ), and Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TIF DOWNLOAD: http://MarketSourceResearch.com/register/?so=TIF KMX DOWNLOAD: http://MarketSourceResearch.com/register/?so=KMX CARS DOWNLOAD: http://MarketSourceResearch.com/register/?so=CARS RES DOWNLOAD: http://MarketSourceResearch.com/register/?so=RES CLF DOWNLOAD: http://MarketSourceResearch.com/register/?so=CLF CATB DOWNLOAD: http://MarketSourceResearch.com/register/?so=CATB

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Tiffany & Co. (NYSE: TIF ), CarMax, Inc. (NYSE: KMX ), Cars.com Inc. (NYSE: CARS ), RPC, Inc. (NYSE: RES ), Cleveland-Cliffs Inc. (NYSE: CLF ), and Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 25th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

TIFFANY & CO. (TIF) REPORT OVERVIEW

Tiffany's Recent Financial Performance

For the three months ended October 31st, 2018 vs October 31st, 2017, Tiffany reported revenue of $1,012.40MM vs $976.20MM (up 3.71%) and analysts estimated basic earnings per share $0.78 vs $0.81 (down 3.70%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, Tiffany reported revenue of $4,169.80MM vs $4,001.80MM (up 4.20%) and analysts estimated basic earnings per share $2.97 vs $3.57 (down 16.81%). Analysts expect earnings to be released on March 15th, 2019. The report will be for the fiscal period ending January 31st, 2019. The reported EPS for the same quarter last year was $1.67. The estimated EPS forecast for the next fiscal year is $4.87 and is expected to report on March 15th, 2019.

To read the full Tiffany & Co. (TIF) report, download it here: http://MarketSourceResearch.com/register/?so=TIF

-----------------------------------------

CARMAX, INC. (KMX) REPORT OVERVIEW

CarMax's Recent Financial Performance

For the three months ended November 30th, 2018 vs November 30th, 2017, CarMax reported revenue of $4,295.87MM vs $4,107.02MM (up 4.60%) and analysts estimated basic earnings per share $1.09 vs $0.82 (up 32.93%). For the twelve months ended February 28th, 2018 vs February 28th, 2017, CarMax reported revenue of $17,120.21MM vs $15,875.12MM (up 7.84%) and analysts estimated basic earnings per share $3.64 vs $3.29 (up 10.64%). Analysts expect earnings to be released on April 3rd, 2019. The report will be for the fiscal period ending February 28th, 2019. Reported EPS for the same quarter last year was $0.77. The estimated EPS forecast for the next fiscal year is $5.07 and is expected to report on April 3rd, 2019.

To read the full CarMax, Inc. (KMX) report, download it here: http://MarketSourceResearch.com/register/?so=KMX

-----------------------------------------

CARS.COM INC. (CARS) REPORT OVERVIEW

Cars' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cars reported revenue of $169.31MM vs $159.90MM (up 5.89%) and analysts estimated basic earnings per share $0.23 vs $0.29 (down 20.69%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cars reported revenue of $626.26MM vs $633.11MM (down 1.08%) and analysts estimated basic earnings per share $3.13 vs $2.46 (up 27.24%). Analysts expect earnings to be released on March 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.47. The estimated EPS forecast for the next fiscal year is $2.37 and is expected to report on March 5th, 2019.

To read the full Cars.com Inc. (CARS) report, download it here: http://MarketSourceResearch.com/register/?so=CARS

-----------------------------------------

RPC, INC. (RES) REPORT OVERVIEW

RPC's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, RPC reported revenue of $439.99MM vs $471.00MM (down 6.58%) and basic earnings per share $0.23 vs $0.26 (down 11.54%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, RPC reported revenue of $1,595.23MM vs $728.97MM (up 118.83%) and analysts estimated basic earnings per share $0.75 vs -$0.66. Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.24. The estimated EPS forecast for the next fiscal year is $0.64 and is expected to report on January 22nd, 2020.

To read the full RPC, Inc. (RES) report, download it here: http://MarketSourceResearch.com/register/?so=RES

-----------------------------------------

CLEVELAND-CLIFFS INC. (CLF) REPORT OVERVIEW

Cleveland-Cliffs' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Cleveland-Cliffs reported revenue of $741.80MM vs $596.70MM (up 24.32%) and analysts estimated basic earnings per share $1.47 vs $0.18 (up 716.67%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cleveland-Cliffs reported revenue of $2,330.20MM vs $2,109.00MM (up 10.49%) and analysts estimated basic earnings per share $1.28 vs $0.88 (up 45.45%). Analysts expect earnings to be released on February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.26. The estimated EPS forecast for the next fiscal year is $1.62 and is expected to report on February 8th, 2019.

To read the full Cleveland-Cliffs Inc. (CLF) report, download it here: http://MarketSourceResearch.com/register/?so=CLF

-----------------------------------------

CATABASIS PHARMACEUTICALS, INC. (CATB) REPORT OVERVIEW

Catabasis Pharmaceuticals' Recent Financial Performance

Analysts expect earnings to be released on March 21st, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$2.40. The estimated EPS forecast for the next fiscal year is -$3.90 and is expected to report on March 21st, 2019.

To read the full Catabasis Pharmaceuticals, Inc. (CATB) report, download it here: http://MarketSourceResearch.com/register/?so=CATB

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Hugo Moreau, Media Department Office: +1 (704) 343-6361 E-mail: media@MarketSourceResearch.com

© 2019 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 200

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 245

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 238

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 286

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 151

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading

Top 5 Most Recently Viewed Articles

Avacta Therapeutics Showcases Promising FAP-Dox Data at ESMO

Updated Category News Views 196

Avacta Therapeutics Presents FAP-Dox Data at International Congress Avacta Therapeutics, a pioneering life sciences company, is set to present an exciting update regarding their innovative drug FAP-Dox (AVA6000) at an esteemed international oncology congress. This event will spotlight groundbreaking research and clinical advancements in targeted cancer treatments that can...

Continue Reading
Qvinci and Harmonyze Join Forces to Revolutionize Franchise Coaching

Updated Category News Views 163

Strategic Collaboration Between Qvinci and Harmonyze In a remarkable development, Qvinci Software, renowned for its innovative franchise financial performance solutions, has announced a pivotal partnership with Harmonyze, an AI-driven performance coaching platform. This collaboration is designed to assist franchisors in transforming intricate financial insights into...

Continue Reading
Citi Remains Optimistic on Capgemini Amid Margin Growth

Updated Category News Views 198

Outlook for Capgemini Stock Citi analyst Balajee Tirupati has recently made adjustments to the price target for Capgemini SE (CAP:FP) (OTC: CAPMF), reducing it to €215 from €225. Despite this revision, Citi has maintained a positive stance, continuing to endorse a Buy rating for Capgemini's stock. Weaker Third-Quarter Update Capgemini's recent third-quarter report for...

Continue Reading
Beyond Oil Marks Key Milestone with Initial Shipment to T&J Oil

Updated Category News Views 252

Beyond Oil's Successful Expansion into the Australian Market Following its commitment to health and sustainability, Beyond Oil Ltd. (CSE: BOIL, OTCQB: BEOLF) has successfully delivered its first shipment of 5.4 tonnes of proprietary oil treatment products to T&J Oil Pty Ltd. This marks an important leap for the company as it steps into the Australian distribution arena,...

Continue Reading
Donaldson Partners with the Special Olympics to Inspire Change

Updated Category News Views 87

Donaldson's Commitment to Community Engagement Donaldson Company, Inc. (NYSE: DCI), a leader in innovative filtration solutions, has taken a significant step towards community engagement by announcing its partnership with the 2026 Special Olympics USA Games. This event is set to create a platform for inclusion, offering athletes with diverse abilities an opportunity to...

Continue Reading